Response of canine mast cell tumors to treatment with oral prednisone

Twenty‐five dogs with naturally occurring mast cell tumors were treated with daily oral prednisone (1 mg/kg) for 28 days. Five dogs (20%) had reduction in tumor volume and were considered responders. Four of these underwent partial remission and one underwent complete remission. Survival times for t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of veterinary internal medicine 1994-11, Vol.8 (6), p.406-408
Hauptverfasser: McCaw, D.L. (University of Missouri, Columbia, MO.), Miller, M.A, Ogilvie, G.K, Withrow, S.J, Brewer, W.G. Jr, Klein, M.K, Bell, F.W, Anderson, S.K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 408
container_issue 6
container_start_page 406
container_title Journal of veterinary internal medicine
container_volume 8
creator McCaw, D.L. (University of Missouri, Columbia, MO.)
Miller, M.A
Ogilvie, G.K
Withrow, S.J
Brewer, W.G. Jr
Klein, M.K
Bell, F.W
Anderson, S.K
description Twenty‐five dogs with naturally occurring mast cell tumors were treated with daily oral prednisone (1 mg/kg) for 28 days. Five dogs (20%) had reduction in tumor volume and were considered responders. Four of these underwent partial remission and one underwent complete remission. Survival times for the five responders were 3, 5, 6, 7.5, and greater than 28 months, respectively. We therefore conclude that prednisone is effective in some canine mast cell tumors. Further studies are indicated to determine the most effective dose of prednisone, the appropriate duration of treatment, and the efficacy in more benign mast cell tumors, and in combination with other forms of therapy.
doi_str_mv 10.1111/j.1939-1676.1994.tb03259.x
format Article
fullrecord <record><control><sourceid>proquest_24P</sourceid><recordid>TN_cdi_proquest_miscellaneous_902328797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77790339</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5116-707e60e6bd192c4b47dc33fd3fa8ab6c0ff0f18c206a7eda9abaeebe8b9fc6e83</originalsourceid><addsrcrecordid>eNqVkF1v0zAUhq0JNLqxP4CEZHHBrlLsOPEHNxNMowx1m9Qxdmk5zjGkJHGxXa379yRK1UskfGNL73PeYz0IvaNkTofzYT2niqmMcsGHlyrmqSIsL9V8d4Rmh-gFmhGpaMZ5QV6hkxjXhORlWYpjdCykLETOZ-hqBXHj-wjYO2xN3_SAOxMTttC2OG07HyJOHqcAJnXQJ_zUpF_YB9PiTYC6b6Lv4TV66Uwb4Wx_n6KHL1ffL79my7vF9eWnZWZLSnkmiABOgFc1VbktqkLUljFXM2ekqbglzhFHpc0JNwJqo0xlACqQlXKWg2Sn6Hzq3QT_Zwsx6a6J409ND34btSI5y6VQYiDf_5MUQijCmBrAjxNog48xgNOb0HQmPGtK9Ghbr_WoVI9K9Whb723r3TD8dr9lW3VQH0b3eof8Ysqfmhae_6NZf_txfVOQsSGbGpqYYHdoMOG35oKJUj_eLvRitbh5vP281KuBfzPxznhtfoYm6od7VfJcyYL9BbtBqP0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77790339</pqid></control><display><type>article</type><title>Response of canine mast cell tumors to treatment with oral prednisone</title><source>Wiley Online Library Open Access</source><creator>McCaw, D.L. (University of Missouri, Columbia, MO.) ; Miller, M.A ; Ogilvie, G.K ; Withrow, S.J ; Brewer, W.G. Jr ; Klein, M.K ; Bell, F.W ; Anderson, S.K</creator><creatorcontrib>McCaw, D.L. (University of Missouri, Columbia, MO.) ; Miller, M.A ; Ogilvie, G.K ; Withrow, S.J ; Brewer, W.G. Jr ; Klein, M.K ; Bell, F.W ; Anderson, S.K</creatorcontrib><description>Twenty‐five dogs with naturally occurring mast cell tumors were treated with daily oral prednisone (1 mg/kg) for 28 days. Five dogs (20%) had reduction in tumor volume and were considered responders. Four of these underwent partial remission and one underwent complete remission. Survival times for the five responders were 3, 5, 6, 7.5, and greater than 28 months, respectively. We therefore conclude that prednisone is effective in some canine mast cell tumors. Further studies are indicated to determine the most effective dose of prednisone, the appropriate duration of treatment, and the efficacy in more benign mast cell tumors, and in combination with other forms of therapy.</description><identifier>ISSN: 0891-6640</identifier><identifier>EISSN: 1939-1676</identifier><identifier>DOI: 10.1111/j.1939-1676.1994.tb03259.x</identifier><identifier>PMID: 7884726</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Administration, Oral ; Animals ; CELULAS FIBROSAS ; CHIEN ; Dog Diseases - drug therapy ; DOGS ; DRUG THERAPY ; Female ; GLUCOCORTICOIDE ; GLUCOCORTICOIDES ; GLUCOCORTICOIDS ; Male ; MALIGNANT COURSE ; MAST CELLS ; Mast-Cell Sarcoma - drug therapy ; Mast-Cell Sarcoma - veterinary ; MASTOCYTE ; NEOPLASM REGRESSION ; Neoplasm Staging - veterinary ; NEOPLASMAS ; NEOPLASME ; NEOPLASMS ; PATHOGENESE ; PATHOGENESIS ; PATOGENESIS ; PERRO ; Prednisone - administration &amp; dosage ; Prednisone - therapeutic use ; Prospective Studies ; RELAPSE ; Remission Induction ; Skin Neoplasms - drug therapy ; Skin Neoplasms - veterinary ; SUPERVIVENCIA ; SURVIE ; SURVIVAL ; TERAPEUTICA MEDICAMENTOSA ; THERAPEUTIQUE MEDICAMENTEUSE</subject><ispartof>Journal of veterinary internal medicine, 1994-11, Vol.8 (6), p.406-408</ispartof><rights>1994 American College of Veterinary Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5116-707e60e6bd192c4b47dc33fd3fa8ab6c0ff0f18c206a7eda9abaeebe8b9fc6e83</citedby><cites>FETCH-LOGICAL-c5116-707e60e6bd192c4b47dc33fd3fa8ab6c0ff0f18c206a7eda9abaeebe8b9fc6e83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1939-1676.1994.tb03259.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1939-1676.1994.tb03259.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,11541,27901,27902,45550,45551,46027,46451</link.rule.ids><linktorsrc>$$Uhttps://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1939-1676.1994.tb03259.x$$EView_record_in_Wiley-Blackwell$$FView_record_in_$$GWiley-Blackwell</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7884726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McCaw, D.L. (University of Missouri, Columbia, MO.)</creatorcontrib><creatorcontrib>Miller, M.A</creatorcontrib><creatorcontrib>Ogilvie, G.K</creatorcontrib><creatorcontrib>Withrow, S.J</creatorcontrib><creatorcontrib>Brewer, W.G. Jr</creatorcontrib><creatorcontrib>Klein, M.K</creatorcontrib><creatorcontrib>Bell, F.W</creatorcontrib><creatorcontrib>Anderson, S.K</creatorcontrib><title>Response of canine mast cell tumors to treatment with oral prednisone</title><title>Journal of veterinary internal medicine</title><addtitle>J Vet Intern Med</addtitle><description>Twenty‐five dogs with naturally occurring mast cell tumors were treated with daily oral prednisone (1 mg/kg) for 28 days. Five dogs (20%) had reduction in tumor volume and were considered responders. Four of these underwent partial remission and one underwent complete remission. Survival times for the five responders were 3, 5, 6, 7.5, and greater than 28 months, respectively. We therefore conclude that prednisone is effective in some canine mast cell tumors. Further studies are indicated to determine the most effective dose of prednisone, the appropriate duration of treatment, and the efficacy in more benign mast cell tumors, and in combination with other forms of therapy.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>CELULAS FIBROSAS</subject><subject>CHIEN</subject><subject>Dog Diseases - drug therapy</subject><subject>DOGS</subject><subject>DRUG THERAPY</subject><subject>Female</subject><subject>GLUCOCORTICOIDE</subject><subject>GLUCOCORTICOIDES</subject><subject>GLUCOCORTICOIDS</subject><subject>Male</subject><subject>MALIGNANT COURSE</subject><subject>MAST CELLS</subject><subject>Mast-Cell Sarcoma - drug therapy</subject><subject>Mast-Cell Sarcoma - veterinary</subject><subject>MASTOCYTE</subject><subject>NEOPLASM REGRESSION</subject><subject>Neoplasm Staging - veterinary</subject><subject>NEOPLASMAS</subject><subject>NEOPLASME</subject><subject>NEOPLASMS</subject><subject>PATHOGENESE</subject><subject>PATHOGENESIS</subject><subject>PATOGENESIS</subject><subject>PERRO</subject><subject>Prednisone - administration &amp; dosage</subject><subject>Prednisone - therapeutic use</subject><subject>Prospective Studies</subject><subject>RELAPSE</subject><subject>Remission Induction</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Skin Neoplasms - veterinary</subject><subject>SUPERVIVENCIA</subject><subject>SURVIE</subject><subject>SURVIVAL</subject><subject>TERAPEUTICA MEDICAMENTOSA</subject><subject>THERAPEUTIQUE MEDICAMENTEUSE</subject><issn>0891-6640</issn><issn>1939-1676</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkF1v0zAUhq0JNLqxP4CEZHHBrlLsOPEHNxNMowx1m9Qxdmk5zjGkJHGxXa379yRK1UskfGNL73PeYz0IvaNkTofzYT2niqmMcsGHlyrmqSIsL9V8d4Rmh-gFmhGpaMZ5QV6hkxjXhORlWYpjdCykLETOZ-hqBXHj-wjYO2xN3_SAOxMTttC2OG07HyJOHqcAJnXQJ_zUpF_YB9PiTYC6b6Lv4TV66Uwb4Wx_n6KHL1ffL79my7vF9eWnZWZLSnkmiABOgFc1VbktqkLUljFXM2ekqbglzhFHpc0JNwJqo0xlACqQlXKWg2Sn6Hzq3QT_Zwsx6a6J409ND34btSI5y6VQYiDf_5MUQijCmBrAjxNog48xgNOb0HQmPGtK9Ghbr_WoVI9K9Whb723r3TD8dr9lW3VQH0b3eof8Ysqfmhae_6NZf_txfVOQsSGbGpqYYHdoMOG35oKJUj_eLvRitbh5vP281KuBfzPxznhtfoYm6od7VfJcyYL9BbtBqP0</recordid><startdate>199411</startdate><enddate>199411</enddate><creator>McCaw, D.L. (University of Missouri, Columbia, MO.)</creator><creator>Miller, M.A</creator><creator>Ogilvie, G.K</creator><creator>Withrow, S.J</creator><creator>Brewer, W.G. Jr</creator><creator>Klein, M.K</creator><creator>Bell, F.W</creator><creator>Anderson, S.K</creator><general>Blackwell Publishing Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>199411</creationdate><title>Response of canine mast cell tumors to treatment with oral prednisone</title><author>McCaw, D.L. (University of Missouri, Columbia, MO.) ; Miller, M.A ; Ogilvie, G.K ; Withrow, S.J ; Brewer, W.G. Jr ; Klein, M.K ; Bell, F.W ; Anderson, S.K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5116-707e60e6bd192c4b47dc33fd3fa8ab6c0ff0f18c206a7eda9abaeebe8b9fc6e83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>CELULAS FIBROSAS</topic><topic>CHIEN</topic><topic>Dog Diseases - drug therapy</topic><topic>DOGS</topic><topic>DRUG THERAPY</topic><topic>Female</topic><topic>GLUCOCORTICOIDE</topic><topic>GLUCOCORTICOIDES</topic><topic>GLUCOCORTICOIDS</topic><topic>Male</topic><topic>MALIGNANT COURSE</topic><topic>MAST CELLS</topic><topic>Mast-Cell Sarcoma - drug therapy</topic><topic>Mast-Cell Sarcoma - veterinary</topic><topic>MASTOCYTE</topic><topic>NEOPLASM REGRESSION</topic><topic>Neoplasm Staging - veterinary</topic><topic>NEOPLASMAS</topic><topic>NEOPLASME</topic><topic>NEOPLASMS</topic><topic>PATHOGENESE</topic><topic>PATHOGENESIS</topic><topic>PATOGENESIS</topic><topic>PERRO</topic><topic>Prednisone - administration &amp; dosage</topic><topic>Prednisone - therapeutic use</topic><topic>Prospective Studies</topic><topic>RELAPSE</topic><topic>Remission Induction</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Skin Neoplasms - veterinary</topic><topic>SUPERVIVENCIA</topic><topic>SURVIE</topic><topic>SURVIVAL</topic><topic>TERAPEUTICA MEDICAMENTOSA</topic><topic>THERAPEUTIQUE MEDICAMENTEUSE</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McCaw, D.L. (University of Missouri, Columbia, MO.)</creatorcontrib><creatorcontrib>Miller, M.A</creatorcontrib><creatorcontrib>Ogilvie, G.K</creatorcontrib><creatorcontrib>Withrow, S.J</creatorcontrib><creatorcontrib>Brewer, W.G. Jr</creatorcontrib><creatorcontrib>Klein, M.K</creatorcontrib><creatorcontrib>Bell, F.W</creatorcontrib><creatorcontrib>Anderson, S.K</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of veterinary internal medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>McCaw, D.L. (University of Missouri, Columbia, MO.)</au><au>Miller, M.A</au><au>Ogilvie, G.K</au><au>Withrow, S.J</au><au>Brewer, W.G. Jr</au><au>Klein, M.K</au><au>Bell, F.W</au><au>Anderson, S.K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response of canine mast cell tumors to treatment with oral prednisone</atitle><jtitle>Journal of veterinary internal medicine</jtitle><addtitle>J Vet Intern Med</addtitle><date>1994-11</date><risdate>1994</risdate><volume>8</volume><issue>6</issue><spage>406</spage><epage>408</epage><pages>406-408</pages><issn>0891-6640</issn><eissn>1939-1676</eissn><abstract>Twenty‐five dogs with naturally occurring mast cell tumors were treated with daily oral prednisone (1 mg/kg) for 28 days. Five dogs (20%) had reduction in tumor volume and were considered responders. Four of these underwent partial remission and one underwent complete remission. Survival times for the five responders were 3, 5, 6, 7.5, and greater than 28 months, respectively. We therefore conclude that prednisone is effective in some canine mast cell tumors. Further studies are indicated to determine the most effective dose of prednisone, the appropriate duration of treatment, and the efficacy in more benign mast cell tumors, and in combination with other forms of therapy.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>7884726</pmid><doi>10.1111/j.1939-1676.1994.tb03259.x</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0891-6640
ispartof Journal of veterinary internal medicine, 1994-11, Vol.8 (6), p.406-408
issn 0891-6640
1939-1676
language eng
recordid cdi_proquest_miscellaneous_902328797
source Wiley Online Library Open Access
subjects Administration, Oral
Animals
CELULAS FIBROSAS
CHIEN
Dog Diseases - drug therapy
DOGS
DRUG THERAPY
Female
GLUCOCORTICOIDE
GLUCOCORTICOIDES
GLUCOCORTICOIDS
Male
MALIGNANT COURSE
MAST CELLS
Mast-Cell Sarcoma - drug therapy
Mast-Cell Sarcoma - veterinary
MASTOCYTE
NEOPLASM REGRESSION
Neoplasm Staging - veterinary
NEOPLASMAS
NEOPLASME
NEOPLASMS
PATHOGENESE
PATHOGENESIS
PATOGENESIS
PERRO
Prednisone - administration & dosage
Prednisone - therapeutic use
Prospective Studies
RELAPSE
Remission Induction
Skin Neoplasms - drug therapy
Skin Neoplasms - veterinary
SUPERVIVENCIA
SURVIE
SURVIVAL
TERAPEUTICA MEDICAMENTOSA
THERAPEUTIQUE MEDICAMENTEUSE
title Response of canine mast cell tumors to treatment with oral prednisone
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T18%3A09%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_24P&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20of%20canine%20mast%20cell%20tumors%20to%20treatment%20with%20oral%20prednisone&rft.jtitle=Journal%20of%20veterinary%20internal%20medicine&rft.au=McCaw,%20D.L.%20(University%20of%20Missouri,%20Columbia,%20MO.)&rft.date=1994-11&rft.volume=8&rft.issue=6&rft.spage=406&rft.epage=408&rft.pages=406-408&rft.issn=0891-6640&rft.eissn=1939-1676&rft_id=info:doi/10.1111/j.1939-1676.1994.tb03259.x&rft_dat=%3Cproquest_24P%3E77790339%3C/proquest_24P%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77790339&rft_id=info:pmid/7884726&rfr_iscdi=true